Previous studies have also reported a consistent and significant decrease in SPP2 expression in tumors, with reduced SPP2 levels in hepatocellular carcinoma (HCC) being associated with advanced clinical and pathological features, indicating a potential tumor-suppressive role for SPP2 in HCC (65). The gene discussed is SPP2; the disease is neoplasm.